Alora Pharmaceuticals Acquires Osmotica's Legacy U.S. Business
August 30, 2021
Alora Pharmaceuticals, LLC closed the acquisition of Osmotica Pharmaceuticals plc's legacy U.S. business (including Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC and Trigen Laboratories, LLC) and the Marietta, Georgia manufacturing facility on August 27, 2021. Osmotica received approximately $111 million in proceeds, which it said would be used to retire a substantial portion of outstanding debt and to focus the company on its ophthalmic product UPNEEQ.
- Buyers
- Alora Pharmaceuticals, LLC
- Targets
- Osmotica Pharmaceutical US LLC, Vertical Pharmaceuticals, LLC, Trigen Laboratories, LLC, Marietta, Georgia manufacturing facility (Osmotica)
- Sellers
- Osmotica Pharmaceuticals plc
- Industry
- Pharmaceuticals
- Location
- New Jersey, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.